Macclesfield, United Kingdom

Keith Raymond Mulholland


 

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Keith Raymond Mulholland

Introduction

Keith Raymond Mulholland is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on innovative methods for the manufacture of complex chemical compounds.

Latest Patents

One of his latest patents is titled "Method for the manufacture of 3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine and polymorphic forms thereof." This specification generally relates to an improved method for the manufacture of this compound, or pharmaceutically acceptable salts thereof, along with polymorphic forms and intermediates useful in the manufacture of such compounds and salts. Another significant patent is for a phthalazinone derivative, specifically "4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one as crystalline Form A."

Career Highlights

Throughout his career, Mulholland has worked with prominent companies in the pharmaceutical industry, including Kudos Pharmaceuticals Limited and AstraZeneca. His expertise in chemical manufacturing and innovative processes has made him a valuable asset in these organizations.

Collaborations

Mulholland has collaborated with several professionals in his field, including Keith Allan Menear and Anthony Peter Ottridge. These collaborations have likely contributed to the advancement of his research and patent developments.

Conclusion

Keith Raymond Mulholland's contributions to the field of pharmaceuticals through his patents and collaborations highlight his innovative spirit and dedication to advancing chemical manufacturing processes. His work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…